SCHEMBL7296996

SCHEMBL7296996

CCOC(=O)N1CCN(c2nc3cc(-c4ccccc4)sc3n3cccc23)CC1

nearest known ligand 0.69

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 6/20 0.69
HTR2C P28335 5/20 0.69
HTR3E A5X5Y0 1/20 0.59
HTR3B O95264 1/20 0.59
HTR3A P46098 1/20 0.59
HTR3D Q70Z44 1/20 0.59
HTR3C Q8WXA8 1/20 0.59
KMT2A Q03164 7/20 0.49
MEN1 O00255 5/20 0.49
ATM Q13315 1/20 0.48
KDM4E B2RXH2 1/20 0.47
NPC1 O15118 1/20 0.45
ALDH1A1 P00352 1/20 0.45
RAB9A P51151 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
RXFP1 Q9HBX9 1/20 0.45
CNR2 P34972 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7296771 0.82 HTR1A (1.00) HTR1AHTR2CHTR3EHTR3BHTR3A
SCHEMBL8567429 0.81 HTR3E (0.75) HTR1AHTR2CHTR3EHTR3BHTR3A
SCHEMBL7295524 0.81 HTR1A (1.00) HTR1AHTR2CHTR3EHTR3BHTR3A
SCHEMBL7306033 0.78 HTR2C (1.00) HTR1AHTR2CHTR3EHTR3BHTR3A
SCHEMBL8571641 0.76 HTR3E (0.64) HTR1AHTR2CHTR3EHTR3BHTR3A
SCHEMBL8566903 0.75 HTR3E (1.00) HTR1AHTR2CHTR3EHTR3BHTR3A
SCHEMBL7296823 0.74 HTR2C (0.75) HTR1AHTR2CHTR3EHTR3BHTR3A
SCHEMBL7305295 0.72 HTR2C (0.63) HTR1AHTR2CHTR3EHTR3BHTR3A
SCHEMBL1753190 0.67 KMT2A (0.66) KMT2AMEN1ATMKDM4EALDH1A1
SCHEMBL13033531 0.67 SMO (0.55) KMT2AMEN1ATMKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0573360-B1 Pyrrolothienopyrazine compounds as 5-HT3 receptors antagonists ADIR (FR) 1998-08-26 EP disclosed
EP-0573360-A1 Pyrrolothienopyrazine compounds as 5-HT3 receptors antagonists ADIR ET COMPAGNIE (FR) 1993-12-08 EP disclosed